Novolyze, a company specialized in Preventive Control Validation, recently announced the addition of 4 new references to its SurroNov range of dry and ready-to-use surrogate microorganisms. With these new products, Novolyze offers an off-the-shelf solution to the food industry for assessing the impact of a thermal process - such as baking, extrusion, drying, etc. - on the inactivation of Salmonella. The released products aim at facilitating preventive control validation studies for the following food applications:
Nuts & Seeds (SurroNov 1822)
Pet Food & Animal Feed (SurroNov 1824)
Herbs & Spices (SurroNov 1826)
Biscuits & Snacks (SurroNov 1832)
These four new items have been tested to have a similar / greater resistance than Salmonella in their respective food application. Tests included inactivation studies on such food matrices as kernel pistachios, pet food kibbles, black pepper, paprika and cookie dough.
As a reminder, surrogate microorganisms are non-pathogenic bacteria that mimic the behavior of foodborne pathogens to different kinds of stress (heat etc.). Since they are not pathogenic, they can be safely used in-plant to validate the efficacy of a preventive control, a cornerstone requirement of FSMA. SurroNov surrogate microorganisms are commercialized as a ready-to-use powder preparation that does not require any further enrichment step before use. They are available in individual pouches from 25g to 1kg at concentrations up to 10-log CFU/g. Their inoculation on a food product is usually obtained by blending.
Novolyze has already announced the launch of new surrogate references in the near future, to cover different food applications.
Contact
Pierre-Olivier BEAL Business Development Manager
T (France) : +33 781 865 563
T (USA) : +1 (617) 500-8536


JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Meta Expands AI Training With Employee Activity Tracking Tools
John Ternus Signals Apple’s Future with Product-First AI Strategy
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 



